The genomic response of Ishikawa cells to bisphenol A exposure is dose- and time-dependent

Toxicology

Volumn 270, Issue 2-3, 2010, Pages 137-149

  Naciff, Jorge M ^a   Khambatta, Zubin S ^a   Reichling, Timothy D ^a   Carr, Gregory J ^a   Tiesman, Jay P ^a   Singleton, David W ^b   Khan, Sohaib A ^b   Daston, George P ^a  

^a PROCTER AND GAMBLE COMPANY   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Bisphenol A; Gene expression profiling; Human uterus; In vitro; Ishikawa cells; Microarrays

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ETHINYLESTRADIOL;

ARTICLE; BIOGENESIS; CANCER CELL CULTURE; CELL PROLIFERATION; CELL TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; ESTROGEN ACTIVITY; EXPOSURE; EXPRESSED SEQUENCE TAG; FEMALE; GENE EXPRESSION PROFILING; GENOMICS; HUMAN; HUMAN CELL; IN VITRO STUDY; ISHIKAWA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; TREND STUDY; UNINDEXED SEQUENCE; UTERUS;

AIR POLLUTANTS, OCCUPATIONAL; ANIMALS; CELL LINE; DATA INTERPRETATION, STATISTICAL; DNA FINGERPRINTING; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOMETRIUM; ESTROGENS, NON-STEROIDAL; FEMALE; HUMANS; PHENOLS; PREGNANCY; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TIME FACTORS; UTERUS;

RATTUS;

EID: 77950021154     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2010.02.008     Document Type: Article

References (37)

1. Boehme K., Simon S., Mueller S.O. Gene expression profiling in Ishikawa cells: a fingerprint for estrogen active compounds. Toxicol. Appl. Pharmacol. 2009, 236:85-96.
2. Boonyaratanakornkit V., Edwards D.P. Receptor mechanisms mediating non-genomic actions of sex steroids. Semin. Reprod. Med. 2007, 25:139-153.
3. Bredhult C., Sahlin L., Olovsson M. Gene expression analysis of human endometrial endothelial cells exposed to Bisphenol A. Reprod. Toxicol. 2009, 28:18-25.
4. Chapin R.E., Adams J., Boekelheide K., Gray L.E., Hayward S.W., Lees P.S., McIntyre B.S., Portier K.M., Schnorr T.M., Selevan S.G., Vandenbergh J.G., Woskie S.R. NTP-CERHR expert panel report on the reproductive and developmental toxicity of bisphenol A. Birth Defects Res. B Dev. Reprod. Toxicol. 2008, 83:157-395.
5. Croxtall J.D., Elder M.G., White J.O. Hormonal control of proliferation in the Ishikawa endometrial adenocarcinoma cell line. J. Steroid. Biochem. 1990, 35:665-669.
6. Gould J.C., Leonard L.S., Maness S.C., Wagner B.L., Conner K., Zacharewski T., Safe S., McDonnell D.P., Gaido K.W. Bisphenol A interacts with the estrogen receptor alpha in a distinct manner from estradiol. Mol. Cell. Endocrinol. 1998, 142:203-214.
7. Gutendorf B., Westendorf J. Comparison of an array of in vitro assays for the assessment of the estrogenic potential of natural and synthetic estrogens, phytoestrogens and xenoestrogens. Toxicology 2001, 166:79-89.
8. Han D.H., Denison M.S., Tachibana H., Yamada K. Relationship between estrogen receptor-binding and estrogenic activities of environmental estrogens and suppression by flavonoids. Biosci. Biotechnol. Biochem. 2002, 66:1479-1487.
9. Ho S.M., Tang W.Y., Belmonte de Frausto J., Prins G.S. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res. 2006, 66:5624-5632.
10. Ikezuki Y., Tsutsumi O., Takai Y., Kamei Y., Taketani Y. Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum. Reprod. 2002, 17:2839-2841.
11. Johnson S.M., Maleki-Dizaji M., Styles J.A., White I.N. Ishikawa cells exhibit differential gene expression profiles in response to oestradiol or 4-hydroxytamoxifen. Endocr. Relat. Cancer 2007, 14:337-350.
12. Kang J.H., Kondo F., Katayama Y. Human exposure to bisphenol A. Toxicology 2006, 226:79-89.
13. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der Burg B., Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139:4252-4263.
14. Lang I.A., Galloway T.S., Scarlett A., Henley W.E., Depledge M., Wallace R.B., Melzer D. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 2008, 300:1303-1310.
15. Lessey B.A., Ilesanmi A.O., Castelbaum A.J., Yuan L., Somkuti S.G., Chwalisz K., Satyaswaroop P.G. Characterization of the functional progesterone receptor in an endometrial adenocarcinoma cell line (Ishikawa): progesterone-induced expression of the alpha1 integrin. J. Steroid. Biochem. Mol. Biol. 1996, 59:31-39.
16. Lovely L.P., Appa-Rao K.B., Gui Y., Lessey B.A. Characterization of androgen receptors in a well-differentiated endometrial adenocarcinoma cell line (Ishikawa). J. Steroid. Biochem. Mol. Biol. 2000, 74:235-241.
17. Naciff J.M., Khambatta Z.S., Thomason R.G., Carr G.J., Tiesman J.P., Singleton D.W., Khan S.A., Daston G.P. The genomic response of a human uterine endometrial adenocarcinoma cell line to 17alpha-ethynyl estradiol. Toxicol. Sci. 2009, 107:40-55.
18. Naciff J.M., Overmann G.J., Torontali S.M., Carr G.J., Khambatta Z.S., Tiesman J.P., Richardson B.D., Daston G.P. Uterine temporal response to acute exposure to 17{alpha}-ethinyl estradiol in the immature rat. Toxicol. Sci. 2007, 97:467-490.
19. Naciff J.M., Hess K.A., Overmann G.J., Torontali S.M., Carr G.J., Tiesman J.P., Foertsch L.M., Richardson B.D., Martinez J.E., Daston G.P. Gene expression changes induced in the testis by transplacental exposure to high and low doses of 17{alpha}-ethynyl estradiol, genistein, or bisphenol A. Toxicol. Sci. 2005, 86:396-416.
20. Naciff J.M., Overmann G.J., Torontali S.M., Carr G.J., Tiesman J.P., Richardson B.D., Daston G.P. Gene expression profile induced by 17alpha-ethynyl estradiol in the prepubertal female reproductive system of the rat. Toxicol. Sci. 2003, 72:314-330.
21. Naciff J.M., Jump M.L., Torontali S.M., Carr G.J., Tiesman J.P., Overmann G.J., Daston G.P. Gene expression profile induced by 17alpha-ethynyl estradiol, bisphenol A, and genistein in the developing female reproductive system of the rat. Toxicol. Sci. 2002, 68:184-199.
22. Nadal A., Ropero A.B., Laribi O., Maillet M., Fuentes E., Soria B. Nongenomic actions of estrogens and xenoestrogens by binding at a plasma membrane receptor unrelated to estrogen receptor alpha and estrogen receptor beta. Proc. Natl. Acad. Sci. USA 2000, 97:11603-21168.
23. Nishida M. The Ishikawa cells from birth to the present. Hum. Cell. 2002, 5:104-117.
24. Nishida M., Kasahara K., Kaneko M., Iwasaki H. Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptors. Nippon Sanka Fujinka Gakkai Zasshi 1985, 37:1103-1111.
25. Okada H., Tokunaga T., Liu X., Takayanagi S., Matsushima A., Shimohigashi Y. Direct evidence revealing structural elements essential for the high binding ability of bisphenol A to human estrogen-related receptor-gamma. Environ. Health Perspect. 2008, 116:32-88.
26. Pennie W.D., Aldridge T.C., Brooks A.N. Differential activation by xenoestrogens of ER alpha and ER beta when linked to different response elements. J. Endocrinol. 1998, 158:R11-R14.
27. Punyadeera C., Dassen H., Klomp J., Dunselman G., Kamps R., Dijcks F., Ederveen A., de Goeij A., Groothuis P. Oestrogen-modulated gene expression in the human endometrium. Cell. Mol. Life Sci. 2005, 62:239-250.
28. Song K.H., Lee K., Choi H.S. Endocrine disrupter bisphenol a induces orphan nuclear receptor Nur77 gene expression and steroidogenesis in mouse testicular Leydig cells. Endocrinology 2002, 143:2208-2215.
29. Takayanagi S., Tokunaga T., Liu X., Okada H., Matsushima A., Shimohigashi Y. Endocrine disruptor bisphenol A strongly binds to human estrogen-related receptor gamma (ERRgamma) with high constitutive activity. Toxicol. Lett. 2006, 167:95-105.
30. Thomas P., Dong J. Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption. J. Steroid Biochem. Mol. Biol. 2006, 102:175-179.
31. Vandenberg L.N., Hauser R., Marcus M., Olea N., Welshons W.V. Human exposure to bisphenol A (BPA). Reprod. Toxicol. 2007, 24:139-177.
32. Volkel W., Colnot T., Csanády G.A., Filser J.G., Dekant W. Metabolism and kinetics of bisphenol a in humans at low doses following oral administration. Chem. Res. Toxicol. 2002, 15:1281-7128.
33. vom Saal F.S., Myers J.P. Bisphenol A and risk of metabolic disorders. JAMA 2008, 300:1353-1355.
34. Watson C.S., Alyea R.A., Jeng Y.J., Kochukov M.Y. Nongenomic actions of low concentration estrogens and xenoestrogens on multiple tissues. Mol. Cell. Endocrinol. 2007, 274:1-7.
35. Ye X., Pierik F.H., Angerer J., Meltzer H.M., Jaddoe V.W., Tiemeier H., Hoppin J.A., Longnecker M.P. Levels of metabolites of organophosphate pesticides, phthalates, and bisphenol A in pooled urine specimens from pregnant women participating in the Norwegian Mother and Child Cohort Study (MoBa). Int. J. Hyg. Environ. Health 2009, 212:481-491.
36. Yokota H., Iwano H., Endo M., Kobayashi T., Inoue H., Ikushiro S., Yuasa A. Glucuronidation of the environmental oestrogen bisphenol A by an isoform of UDP-glucuronosyltransferase, UGT2B1, in the rat liver. Biochem. J. 1999, 340:405-409.
37. Young S.S., Yu M. Association of bisphenol A with diabetes and other abnormalities. JAMA 2009, 301:720-721.